• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New Frontiers in Cardiovascular Pharmacology

Bioengineer by Bioengineer
April 26, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This eBook is edited by Dr. Atta-ur-Rahman and Dr. M. Iqbal Choudhary, published on April 5, 2019

The search for new ways to treat cardiovascular diseases involves research and development efforts for new drugs or to revisit current drugs and review data of clinical results after administration. Bentham Science Publishers’ latest volume of Frontiers in Cardiovascular Drug Discovery book series looks at both approaches, albeit with some interesting perspectives on the latter approach to treating cardiovascular disease. This is exemplified in the first chapter of the volume, which is a review of the pharmacodynamic data of aspirin; the reviewers attempt to ask the question of whether if increasing dose frequency is better than increasing the overall dosage. In the same vein, another review in this volume presents findings of therapy with evolocumab, the monoclonal antibody designed to inhibit the PCSK9 pathway to counter hyperlipidemia, with statins. Readers will also find information about research on stents after clopidogrel withdrawal, adenosine receptor drug targets and immunosuppressive drugs useful for heart transplant surgery.

Frontiers in Cardiovascular Drug Discovery is essential reading for healthcare administrators, clinicians and pharmacologists involved in cardiovascular medicine and research.

###

About The Editors:

Dr. Atta-ur-Rahman

Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 253 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world’s leading encyclopedic series of volumes on natural products “Studies in Natural Product Chemistry” 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.

Dr. M. Iqbal Choudhary

M. Iqbal Choudhary is a Ph. D. scientist in the field of organic chemistry from Pakistan working at the University of Karachi. He is known for his research in bioorganic chemistry and natural product chemistry. He has more than 900 research publications, including 32 books published.

For further details, please visit: https://ebooks.benthamscience.com/book/9781681083995/

Media Contact
Faizan ul Haq
[email protected]

Tags: CardiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Elite Powerlifting Study Reveals the Myth of the Bodyweight Multiplier

September 22, 2026

Evidence Under Fire: New Debate Over How Medication Optimisation Tools Should Be Judged

September 22, 2026

Urinary Incontinence: The Neglected Geriatric Giant Demanding Urgent Action in Care and Research

September 22, 2026

Two Immune Drugs Combined Achieve Dramatic Recovery in Stubborn Psoriatic Arthritis Case

September 21, 2026
Please login to join discussion

POPULAR NEWS

  • Leopard Genomics Paper on South Africa’s Cape Floristic Region Retracted

    29 shares
    Share 12 Tweet 7
  • AI Learns to Forget: New Hypernetwork Framework Enables Data-Free Unlearning

    29 shares
    Share 12 Tweet 7
  • Elite Powerlifting Study Reveals the Myth of the Bodyweight Multiplier

    29 shares
    Share 12 Tweet 7
  • Evidence Under Fire: New Debate Over How Medication Optimisation Tools Should Be Judged

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Leopard Genomics Paper on South Africa’s Cape Floristic Region Retracted

AI Learns to Forget: New Hypernetwork Framework Enables Data-Free Unlearning

Elite Powerlifting Study Reveals the Myth of the Bodyweight Multiplier

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.